KCK

Total investments

38

Average round size

56M

Portfolio companies

20

Rounds per year

4.22

Lead investments

12

Follow on index

0.47

Exits

3

Stages of investment
Early Stage Venture
Areas of investment
BiotechnologySoftwareFinancial ServicesMobileHealth CareMedical DeviceMedicalTherapeuticsEnergyOil and Gas

Summary

The venture was found in North America in United States. The main department of described VC is located in the New York.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the KCK, startups are often financed by Venrock, Piton Capital, Versant Ventures. The meaningful sponsors for the fund in investment in the same round are Sofinnova Partners, Exor Seeds, Venrock. In the next rounds fund is usually obtained by Sofinnova Partners, S-Cubed Capital, Kleiner Perkins.

For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 3 or 5+ of the founder, the probability for it to get the investment is little. We can highlight the next thriving fund investment areas, such as Education, Financial Services. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Earlens Corporation, Affirmed Networks, Wunder Mobility.

The fund was created by Nael Kassar. The overall number of key employees were 4.

Speaking about the real fund results, this VC is 38 percentage points more often commits exit comparing to other organizations. The top amount of exits for fund were in 2014. Deals in the range of 10 - 50 millions dollars are the general things for fund. The important activity for fund was in 2018. Despite it in 2019 the fund had an activity. Opposing the other organizations, this KCK works on 24 percentage points less the average amount of lead investments. The typical startup value when the investment from KCK is 100-500 millions dollars. The fund is constantly included in 2-6 deals per year.

Show more

Investments analytics

Analytics

Total investments
38
Lead investments
12
Exits
3
Rounds per year
4.22
Follow on index
0.47
Investments by industry
  • Health Care (19)
  • Medical Device (17)
  • Medical (11)
  • Therapeutics (7)
  • Biotechnology (7)
  • Show 50 more
Investments by region
  • United States (24)
  • Ireland (5)
  • United Arab Emirates (2)
  • Israel (3)
  • Germany (3)
  • Show 1 more
Peak activity year
2018
Number of Unicorns
4
Number of Decacorns
4
Number of Minotaurs
2

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
12
Avg. valuation at time of investment
600M
Group Appearance index
0.89
Avg. company exit year
10
Avg. multiplicator
9.03
Strategy success index
0.90

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Chain Reaction 23 Feb 2023 Cloud Computing, Data Center, Semiconductor, Blockchain, Privacy Late Stage Venture 70M HaZafon, Yoqne`am `illit, Israel
RefleXion Medical 14 Apr 2016 Health Care, Medical Device, Medical, Therapeutics Early Stage Venture 52M United States, California, Hayward

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.